Home
Company
Therapeutic Focus
Pipeline
- UNI-494
- Oxylanthanum Carbonate (OLC)
Investors
Resources
Contact

Archives: Resources

Oxylanthanum Carbonate (OLC) Sevelamer In-Vivo Phosphate Reduction Study

May 15, 2023
Oxylanthanum Carbonate (OLC) Phosphate Binders Daily Medication Volume Poster

May 15, 2023
UNI-494 DOG 28-Day Oral Toxicity Study

May 15, 2023
UNI-494 InVitro Drug Interaction- Poster

May 15, 2023
Oxylanthanum Carbonate (OLC) – Phase 1 Clinical Study Poster

May 12, 2023
UNI-494 Preclinical PK Poster

May 12, 2023

Legal Notices and Terms of Use
Privacy Policy
Ad and Cookie Policy
Contact Us >

Copyright © 2023 Unicycive

Twitter
LinkedIn